NewAmsterdam Pharma Company (NAMS)
NASDAQ:NAMS
US Market
Holding NAMS?
Track your performance easily

NewAmsterdam Pharma Company (NAMS) Stock Investors

105 Followers
Based on 765,277 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold NAMS
On average, investors allocate 0.00% of their portfolios to NAMS
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Positive
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 765,277 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding NAMS

0.1%
Last 7
Days
17.7%
Last 30
Days
Percentages indicate the change in the number of portfolios holding NAMS, out of 765,277 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

NAMS Investor Activity

Action
Any
Any
Investor Performance
Any
Any
Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Opened
3.04%
$19.00
Based on the activity of 14,632 investors who made their portfolios public
The table shows changes in NAMS in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

NAMS Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
CVS Health
3.97%
-0.53%
-0.67%
68.75B
Healthcare
ServiceNow
4.07%
-0.30%
+2.23%
196.65B
Technology
Viking Therapeutics
4.94%
+3.38%
+4.96%
7.04B
Healthcare
Vistra Energy
4.86%
+0.74%
+16.22%
39.76B
Utilities
First Solar
4.56%
+0.67%
+16.22%
22.73B
Technology
Merck & Company
3.55%
+0.09%
+5.71%
258.22B
Healthcare
Synopsys
3.55%
-0.25%
+14.37%
80.57B
Technology
Enphase Energy
4.83%
-0.66%
+3.02%
11.82B
Technology
Lululemon Athletica
4.64%
-0.62%
-0.70%
40.69B
Consumer Cyclical
Abbott Laboratories
3.65%
+0.83%
+14.94%
204.06B
Healthcare
Based on the activity of 765,277 active portfolios
Open your Smart Portfolio

NAMS Investor Analysis

NAMS investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
15.0%
of NAMS holders
are under 35
Average Segment Performance
Average P/E Ratio23.45
Beta10.33
Dividend Yield51.46%
NAMS investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
65.0%
of NAMS holders
are between 35–55
Average Segment Performance
Average P/E Ratio21.88
Beta20.26
Dividend Yield24.92%
NAMS investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
20.0%
of NAMS holders
are over 55
Average Segment Performance
Average P/E Ratio21.22
Beta8.93
Dividend Yield41.53%
Overview of age group and performance of NAMS stock investors
See who invests in NAMS according to age group and performance.

FAQ

How many retail Investors hold NAMS?
<0.1% of TipRanks' retail investors hold NAMS in their portfolios.
    What is NAMS Investor Sentiment?
    NAMS’s Investor Sentiment is Very Positive.
      What percentage of retail investors changed their holding of NAMS in the last 7 days?
      ▼ 0.1% of TipRanks' retail investors changed their holding of NAMS in the last 7 days.
        What percentage of retail investors changed their holding of NAMS in the last 30 days?
        ▲ 17.7% of TipRanks' retail investors changed their holding of NAMS in the last 30 days.
          What is the average age of retail investors who hold NAMS?
          The average age of NAMS Holders is between 35–55.
            What other stocks have NAMS investors also bought?
            NAMS Investors also bought CVS, NOW, VKTX, VST, FSLR, MRK, SNPS, ENPH, LULU, ABT.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ABTAbbott Laboratories
              AGENAgenus
              AAgilent
              BDXBecton Dickinson
              BIIBBiogen
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis